Lumenis M22 System

Lumenis, Inc.

Country / region:United States (US)Submission type:Traditional

Product code GEX· 21 CFR 878.4810

View Summary PDF

Company

United States (US)

Product code

GEX
21 CFR 878.4810

Predicate devices

6

Cited as predicate

4

Device details

FDA 510(k) registration fields

K number
K142860
Device name
Lumenis M22 System
Country / region
United States(US)
Product code
GEX
Device class
Class 2
Regulation number
21 CFR 878.4810
Date received
2014-10-01
Decision date
2015-01-21
Submission type
Traditional
Technology type
Other(AI inferred)
Clinical applications
Pigment treatmentVascular treatmentSkin resurfacing
Primary application
Pigment treatment
Classification source
AI classified

Indications for Use

The subject Lumenis M22 System has connection capability with the following available treatment handpieces, for multi-application treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows:

1. The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with 8 different filters) is indicated for:
• Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles) and tattoos
• Cutaneous lesions, including warts, scars and striae
• Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations
• Removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles
• Mild to moderate inflammatory Acne (Acne vulgaris)

2. The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for:
• The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm. diameter) of the leg
• The removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles
• The non-ablative treatment of facial wrinkles

3. ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for:
• Use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue

4. The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064nm is indicated for:
• Removal of dark tattoos
• Treatment of pigmented lesions

*Note: Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.

Intended Use

The subject Lumenis M22 System has connection capability with the following available treatment handpieces, for multi-application treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows:

1. The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with 8 different filters) is indicated for:

• Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles) and tattoos
• Cutaneous lesions, including warts, scars and striae
• Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations
• Removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles
• Mild to moderate inflammatory Acne (Acne vulgaris)

2. The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for:
• The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm. diameter) of the leg
• The removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles
• The non-ablative treatment of facial wrinkles

3. ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for:
• Use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue

4. The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064nm is indicated for:
• Removal of dark tattoos
• Treatment of pigmented lesions

*Note: Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.

Device Description

The subject Lumenis M22 System is a multi-application, multi-technology platform with four (4) available treatment handpieces:

• Universal Intense Pulsed Light (IPL) handpiece (K083733)
• Multi-Spot Nd:YAG laser handpiece (K083733)
• ResurFX non-ablative laser handpiece (K130028)
• Q-Switched Nd:YAG laser handpiece (K043173)

Summary parsed at:2026-06-01 06:10:23 UTC

Predicate devices

6

K142860 references 6 predicate/reference devices

Cited as predicate

4

4 submissions cite K142860 as a predicate